Analysts at StockNews.com started coverage on shares of Streamline Health Solutions (NASDAQ:STRM – Get Free Report) in a report released on Sunday. The brokerage set a “sell” rating on the stock.
Separately, Craig Hallum raised shares of Streamline Health Solutions to a “strong-buy” rating in a report on Thursday, September 5th.
View Our Latest Analysis on Streamline Health Solutions
Streamline Health Solutions Stock Down 4.1 %
Streamline Health Solutions (NASDAQ:STRM – Get Free Report) last announced its earnings results on Wednesday, September 11th. The company reported ($0.75) earnings per share for the quarter, missing analysts’ consensus estimates of ($0.60) by ($0.15). Streamline Health Solutions had a negative return on equity of 44.85% and a negative net margin of 92.72%. The business had revenue of $4.48 million during the quarter.
Streamline Health Solutions Company Profile
Streamline Health Solutions, Inc offers health information technology solutions and associated services for hospitals and health systems in the United States and Canada. The company offers RevID, an automated revenue reconciliation software; eValuator, a coding analysis platform; data comparison engine; coding and clinical documentation improvement (CDI) solutions, including CDI, abstracting, and physician query; and financial management solutions, such as accounts receivable management, denials management, claims processing, spend management, and audit management.
Read More
- Five stocks we like better than Streamline Health Solutions
- What is a SEC Filing?
- 2 Chip Stocks Benefitting from OpenAI’s Chip Strategy Expansion
- Best Stocks Under $5.00
- Monday.com’s Manic Price Pullback Is a Signal to Buy
- Ride Out The Recession With These Dividend Kings
- 3 “Made in America” Stocks to Benefit From the Trump Presidency
Receive News & Ratings for Streamline Health Solutions Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Streamline Health Solutions and related companies with MarketBeat.com's FREE daily email newsletter.